Consensus position statement on emerging treatments in dermatology by the Association of Cutaneous Surgeons of India Task Force

The consensus position statement by the Association of Cutaneous Surgeons of India Task Force evaluates six emerging dermatological treatments, including exosomes, PDRNs, and Regenera Activa, focusing on their potential in hair growth and other skin conditions. The study, involving 14 dermatologists, found that most treatments lack robust evidence and FDA approval, with recommendations ranging from moderate to limited. Exosomes and PDRNs show potential but are largely preclinical, while Regenera Activa shows promise in hair loss but requires further research. For androgenetic alopecia, small studies show improvements, but evidence is low, necessitating more robust trials. The document emphasizes cautious use of these treatments under ethical oversight, highlighting the need for informed consent and further research to ensure safety and efficacy.